Jagsonpal Pharmaceuticals Ltd.

View in App
415.35 -7.90 ▼-1.9%

04 October 2023, 03:49:21 PM
Volume: 11,879

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.jagsonpal.com
Market Cap 1,091.67 Cr.
Enterprise Value(EV) 1,002.19 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 11.94 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 34.90 Trailing Twelve Months Ending 2023-06
Industry PE 38.26 Trailing Twelve Months Ending 2023-06
Book Value / Share 60.16 Trailing Twelve Months Ending 2023-06
Price to Book Value 6.93 Calculated using Price: 416.70
Dividend Yield 1.20 Period Ending 2023-03
No. of Shares Subscribed 2.62 Cr. 26,198,000 Shares
FaceValue 5
About Jagsonpal Pharmaceuticals Ltd.
In 1964 Jagsonpal started from humble beginnings with Jagmohan S. Kochhar operating a chemists shop in Delhi. Soon he expanded into making formulations. Mr. Kochhar's vision was to spread health and healing in India on a larger scale. He was at the helm of the company from its inception, through the startup phase. Even though Jagsonpal was a small business at the time, his vision was to create one of India's premiere pharmaceutical companies.

Jagsonpal Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Jagsonpal Pharmaceuticals Ltd. Performance

View details >>
1 Day
-1.87%
1 Week
-1.10%
1 Month
-1.63%
3 Month
+11.59%
6 Month
+37.83%
1 Year
+17.07%
2 Year
+166.93%
5 Year
+1482.29%
10 Year
+4515.00%

Jagsonpal Pharmaceuticals Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 1.35 3.65 12.32 -12.01 7.72 7.88 15.70 15.28 18.89
Return on Capital Employed (%) 4.93 7.32 14.26 -10.52 9.80 9.46 19.43 21.23 24.15
Return on Assets (%) 0.75 2.08 7.86 -8.48 5.43 5.53 10.90 11.24 14.29

Jagsonpal Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 99 95 98 110 98 104 111 122 133 159
Non Curr. Liab. 4 4 4 3 3 3 3 2 4 8
Curr. Liab. 54 55 57 29 29 28 35 40 34 35
Minority Int.
Equity & Liab. 156 154 159 143 130 136 149 164 171 203
Non Curr. Assets 65 58 58 33 35 38 52 44 55 30
Curr. Assets 91 96 101 110 95 98 96 120 116 172
Misc. Exp. not W/O
Total Assets 156 154 159 143 130 136 149 164 171 203

Jagsonpal Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 138 143 144 127 167 159 188 218 237 236
Other Income 0 1 0 0 1 3 4 3 6 7
Total Income 138 144 144 127 168 161 192 221 242 244
Total Expenditure -129 -132 -138 -138 -157 -150 -169 -193 -203 -201
PBIDT 9 12 6 -11 11 11 23 28 40 43
Interest -4 -5 -3 -1 -1 -1 -1 0 0 -1
Depreciation -3 -3 -2 0 -1 -1 -1 -2 -1 -1
Taxation -1 -1 -3 0 -2 -2 -5 -8 -8 -10
Exceptional Items 13 -3
PAT 1 3 12 -12 7 8 17 19 27 31
Adjusted EPS 0 1 5 -4 3 3 7 7 10 12

Jagsonpal Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 8 4 9 -3 -2 31 12 28 7 47
Cash Fr. Inv. -1 0 -2 41 -3 -1 -11 -2 -26 -58
Cash Fr. Finan. -4 -1 -6 -34 -1 -6 -2 -7 -18 0
Net Change 2 2 1 5 -6 24 -1 19 -36 -11
Cash & Cash Eqvt 13 15 16 20 15 39 40 59 23 11

Jagsonpal Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 70.34 70.34 70.34 68.71 68.71 68.72 68.71 68.71 68.71
Public 29.66 29.66 29.66 31.29 31.29 31.28 31.29 31.29 31.29
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Jagsonpal Pharmaceuticals Ltd. Announcements

View details >>
Fri, 29 Sep 2023
Trading Window
Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Thu, 14 Sep 2023
Spurt in Volume
Significant increase in volume has been observed in Jagsonpal Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Jagsonpal Pharmaceuticals Limited has submitted their response.
Wed, 13 Sep 2023
Spurt in Volume
Significant increase in volume has been observed in Jagsonpal Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors

Jagsonpal Pharmaceuticals Ltd. Technical Scans

View details >>
Tue, 03 Oct 2023
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High
Opening at Low for 2 Days Opening at Low for 2 Days
High Increase in 3 Months High Increase in 3 Months

Jagsonpal Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 273,992.06 1,123.80 -1.6%
Divi's Laboratories Ltd. 98,792.80 3,707.75 -0.4%
Cipla Ltd. 95,478.34 1,167.05 -1.3%
Dr. Reddy's Laboratories Ltd. 91,061.15 5,417.80 -0.8%
Apollo Hospitals Enterprise Ltd. 73,583.24 5,047.40 -1.4%
Mankind Pharma Ltd. 72,079.88 1,808.00 +0.5%
Torrent Pharmaceuticals Ltd. 63,636.20 1,864.15 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.48 1,123.80 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-06 66.87 3,707.75 -0.4%
Cipla Ltd. Consolidated 2023-06 30.69 1,167.05 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.28 5,417.80 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 110.06 5,047.40 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 56.25 1,808.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 50.53 1,864.15 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.72 1,123.80 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-06 7.53 3,707.75 -0.4%
Cipla Ltd. Consolidated 2023-06 3.92 1,167.05 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.71 5,417.80 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.73 5,047.40 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 5.89 1,808.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-06 9.68 1,864.15 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,123.80 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,707.75 -0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,167.05 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,417.80 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,047.40 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,808.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 1,864.15 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,123.80 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,707.75 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.05 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,417.80 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,047.40 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,864.15 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,123.80 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,707.75 -0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,167.05 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,417.80 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,047.40 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,808.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 1,864.15 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,123.80 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,707.75 -0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,167.05 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,417.80 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,047.40 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,808.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 1,864.15 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,123.80 -1.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,707.75 -0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,167.05 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,417.80 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,047.40 -1.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,808.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 1,864.15 -0.9%

Jagsonpal Pharmaceuticals Ltd. FAQ's

What is Jagsonpal Pharma share price?
Can I buy Jagsonpal Pharma shares now?
What is the Dividend Yield of Jagsonpal Pharma?
What is the Market Cap of Jagsonpal Pharma?
What are the key metrics to analyse Jagsonpal Pharma?
What is the 52 Week High and Low of Jagsonpal Pharma?
What is the trend of Jagsonpal Pharma share price?